InspectraInspection management
Operational overview
Current workload, planning activity, and upcoming field work.
Frontend preview
View portfolioActive inspections
6
Across your portfolio
In planning
2
Awaiting milestones
Upcoming
6
With planned dates
Portfolio
Recent inspections
| Reference | Organisation & site | Stream | Status | Planned start |
|---|---|---|---|---|
| INS-2026-0142 Routine GMP re-inspection | Northstar Therapeutics Cambridge Manufacturing Campus, United Kingdom | Finished Pharmaceutical Products | Planning | 17 Aug 2026 |
| INS-2026-0138 Initial vaccine facility inspection | Helix Biologics Leiden Biologics Centre, Netherlands | Vaccines | Team Approval Pending | 7 Sept 2026 |
| INS-2026-0129 For-cause laboratory inspection | Atlas Quality Laboratories Dublin Analytical Facility, Ireland | Quality Control Laboratories | Scheduled | 27 Jul 2026 |
| INS-2026-0117 Medical device quality-system inspection | Vela Diagnostics Basel Diagnostics Plant, Switzerland | Diagnostics | In Progress | 20 Jul 2026 |
| INS-2026-0104 API manufacturing follow-up | Arden Active Ingredients Cork API Campus, Ireland | Active Pharmaceutical Ingredients | Peer Review | 8 Jun 2026 |